The Japan Times CENTER (0.0) Reliability: 7.5/10

U.S. investments, and rhetoric, help AstraZeneca seal drug deal with Trump

✍️ Maggie Fick 📅 October 14, 2025 12:00 AM 🕐 Scraped: October 15, 2025

Summary: Deal to lower drug costs for Americans and shield the drugmaker from import tariffs was the culmination of efforts stretching back to November last year, sources say.

AstraZeneca CEO Pascal Soriot looked relaxed standing in the Oval Office on Friday as U.S.

📰

Continue Reading on The Japan Times

This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.

Read Full Article →

How do you feel about this article?

Read Original Article →

📝 Article Information

Author

Maggie Fick

Original Publisher

🌍 The Japan Times

CENTER Bias (0.0)

Published Date

October 14, 2025 at 12:00 AM

ℹ️

Disclaimer

ArkforgeAI.com - Newsource is a news aggregation platform. We do not create, write, or produce original news content. All articles are sourced from their respective publishers and remain the property of their original creators. We analyze and aggregate news from multiple sources to provide diverse perspectives across the political spectrum.

The content displayed here is for informational purposes only. For the complete and original article, please visit the source's website using the "Read Original Article" link above.

Desktop Only